Status:
COMPLETED
Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infection
Lead Sponsor:
POM Wonderful LLC
Conditions:
Common Cold
Eligibility:
All Genders
18-45 years
Phase:
PHASE2
Brief Summary
Pomegranate has a long history of use in folk medicine. There is vast data on the health benefits of pomegranate fruit and juice. Multiple studies have established the strong antioxidative effects of ...
Eligibility Criteria
Inclusion
- Nonsmoker
- No recent history of respiratory disease
Exclusion
- Serum positive for rhinovirus
- Pregnant or breastfeeding
- Recent immunization
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2008
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00655031
Start Date
April 1 2008
End Date
July 1 2008
Last Update
August 18 2008
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Accelovance Inc.
Huntsville, Alabama, United States, 35802
2
Accelovance Inc
Melbourne, Florida, United States, 32935
3
University of Virginia School of Medicine
Charlottesville, Virginia, United States, 22908